Polyglutamine toxicity in non-neuronal cells
Authors:
Open Access
- 16 March 2010
- journal article
- review article
- Published by Springer Nature in Cell Research
- Vol. 20 (4) , 400-407
Abstract
The neurodegenerative polyglutamine diseases are caused by an expansion of unstable polyglutamine repeats in various disease proteins. Although these mutant proteins are expressed ubiquitously in neuronal and non-neuronal cells, they cause selective degeneration of specific neuronal populations. Recently, increasing evidence shows that polyglutamine disease proteins also affect non-neuronal cells. However, it remains unclear how the expression of polyglutamine proteins in non-neuronal cells contributes to the course of the polyglutamine diseases. Here, we discuss recent findings about the expression of mutant polyglutamine proteins in non-neuronal cells and their influence on neurological symptoms. Understanding the contribution of non-neuronal polyglutamine proteins to disease progression will help elucidate disease mechanisms and also help in the development of new treatment options.Keywords
This publication has 88 references indexed in Scilit:
- Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptomsProceedings of the National Academy of Sciences, 2009
- Impaired PGC-1α function in muscle in Huntington's diseaseHuman Molecular Genetics, 2009
- Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse modelsHuman Molecular Genetics, 2009
- Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's diseaseHuman Molecular Genetics, 2008
- Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's diseaseNeurobiology of Disease, 2008
- Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouseNeuroscience, 2008
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- Glial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseNature Neuroscience, 2007
- Cardiac dysfunction in the R6/2 mouse model of Huntington’s diseaseNeurobiology of Disease, 2007
- Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear InclusionsMolecular Cell, 2002